View of Open-Label Randomized Controlled Trial to Assess the Efficacy and Safety of Triple Therapy With Aspirin, Clopidogrel, and Rivaroxaban Versus Dual Therapy With Aspirin and Clopidogrel in Patients With Acute Coronary Syndrome

Return to Article Details Open-Label Randomized Controlled Trial to Assess the Efficacy and Safety of Triple Therapy With Aspirin, Clopidogrel, and Rivaroxaban Versus Dual Therapy With Aspirin and Clopidogrel in Patients With Acute Coronary Syndrome Download Download PDF